Medline Inc. (Nasdaq: MDLN) is a healthcare company focused on medical-surgical ("med-surg") products and supply chain solutions that serve hospitals, surgery centers, physician offices and post-acute care facilities. The Medline news page on Stock Titan highlights company announcements that explain how it operates as what it describes as the largest provider of med-surg products and supply chain solutions serving all points of care, based on total net sales of med-surg products.
News related to Medline often centers on capital markets activity and corporate milestones, such as the public filing of its registration statement on Form S-1 with the U.S. Securities and Exchange Commission, the pricing of its upsized initial public offering of Class A common stock, and the closing of that upsized offering on the Nasdaq Global Select Market under the symbol MDLN. These updates provide context on Medline’s transition to being a publicly traded company and its use of offering proceeds for debt repayment, general corporate purposes and transactions with pre-IPO owners.
Investors and observers can also find Medline announcements about participation in major healthcare and investor conferences, such as the J.P. Morgan Healthcare Conference. Such events can offer additional insight into how the company presents its med-surg product portfolio, supply chain capabilities and clinical solutions to the investment community.
This news page aggregates these types of press releases and corporate communications so readers can review Medline’s official statements over time. For anyone tracking MDLN, the page offers a focused view of the company’s own disclosures about its business focus, public listing, capital structure and engagement with the broader healthcare and financial markets.
Medline (MDLN) announced that selling stockholders have launched an underwritten secondary offering of 60,000,000 shares of its Class A common stock. The sellers include affiliates of Blackstone, Carlyle and Hellman & Friedman, alongside GIC and its managed affiliate and an Abu Dhabi Investment Authority subsidiary. They intend to grant underwriters a 30-day option for up to 9,000,000 additional shares. Medline is selling no shares and will receive no proceeds.
Medline and Medline Holdings agreed to repurchase $200 million of Class A shares and limited partnership interests directly from the sellers at the price paid by underwriters. The repurchase is expected to close concurrently with, and depends on, the offering closing; the reverse condition does not apply. The offering registration statement is not yet effective.
Medline (Nasdaq: MDLN) reported third-quarter net sales of $7.9 billion, up 10.4% from the same period in 2025. Net income fell 1.2% to $318 million, while adjusted EBITDA, a non-GAAP earnings measure, rose 11.8% to $960 million. Diluted earnings per share were $0.22.
For the nine months ended September 26, 2026, sales rose 10.9% to $22.9 billion, but net income fell 28.8% to $696 million. Results included $316 million in net losses from the Tracy, California, distribution-center fire. Operating cash flow was $2.2 billion.
Medline raised its 2026 organic sales growth outlook to 10.0%–10.5% from 9.0%–10.0% and reaffirmed adjusted EBITDA guidance of $3.3 billion–$3.4 billion, excluding tariff refunds. In October, the board authorized repurchases of up to $1 billion in Class A shares and/or Medline Holdings units, and the company prepaid $750 million of term-loan principal.
Medline (Nasdaq: MDLN) is scheduled to present at the Jefferies Global Healthcare Conference in London on November 17, 2026.
Chief executive officer Jim Boyle will present at 3:30pm GMT. A webcast will be available on the Events page at ir.medline.com, with a replay available on Medline’s Investor Relations website for 120 days following the event.
Medline (MDLN) plans to open an approximately 800,000-square-foot distribution center in Van Buren Township, Michigan, to expand its distribution network.
The company expects the facility to begin serving customers across Michigan in late 2028. Medline says the investment will add capacity and operational flexibility to support its growth and healthcare providers in Michigan and the broader Midwest. Ashley Capital is leading development at its Crossroads Distribution Center North industrial park. The facility is expected to use many of the same technologies already deployed at other Medline facilities.
Medline (MDLN) launched an enhanced version of TrackPoint, its online inventory management solution for long-term care and inpatient hospice providers. The platform tracks supplies purchased from Medline and patient-level item usage across locations. It integrates with PointClickCare for real-time patient data syncing and supports barcode scanning and purchasing through Medline.com.
Medline (MDLN) plans to report its third quarter 2026 financial results before the market opens on November 4, 2026.
A webcast and conference call to discuss the results will begin at 9:30am ET / 8:30am CT. Supplemental materials and webcast information will be available on its Investor Relations website, with a replay available after the event.
Medline (MDLN) will participate in the Morgan Stanley 24th Annual Global Healthcare Conference in New York, featuring a presentation by its CEO Jim Boyle and CFO Mike Drazin on Tuesday, September 15, 2026, at 12:20 p.m. ET.
A live webcast and 90-day replay will be available on Medline’s Investor Relations Events page.
Medline (Nasdaq: MDLN) reported second quarter 2026 net sales of $7.7 billion, up 11.6% year over year, with Organic Sales up 11.5%. Net income fell 58.3% to $139 million, mainly due to $336 million in losses from a fire at the Tracy, California distribution center before expected insurance recoveries, along with higher operating expenses and cost of goods sold.
Second quarter Adjusted EBITDA rose 13.4% to $1.06 billion, helped by a net $243 million IEEPA tariff refund benefit, including $332 million of refunds and $89 million of accrued customer repayments. For the first six months, net sales increased 11.1% to $15.0 billion, net income declined 42.3% to $378 million, and Adjusted EBITDA increased 1.9% to $1.84 billion. Net cash from operating activities was $1.1 billion and Free Cash Flow was $920 million. Medline raised its 2026 Organic Sales growth outlook to 9.0%–10.0% and lowered Adjusted EBITDA guidance to $3.3–$3.4 billion, excluding future IEEPA refund benefits.
Medline (Nasdaq: MDLN) plans to open an approximately 1 million-square-foot distribution center in Perris, California, expanding its state network and adding supply chain capacity and flexibility. The project follows a June 11 fire at Medline's Tracy facility and complements over 1.6 million square feet of new Northern California distribution space. With Perris and other recent additions, Medline expects its California distribution footprint to reach nearly 5 million square feet by mid-2027, with facilities incorporating technologies already used at other company sites. IDI Logistics will lead development of the Perris location.
Medline (Nasdaq: MDLN) signed a new Prime Vendor agreement with Allina Health, a Minneapolis-based healthcare system with 12 hospital campuses and more than 90 clinics across Minnesota and western Wisconsin.
The deal gives Allina Health access to Medline's medical-surgical portfolio and distribution capabilities to support supply reliability, consistency and supply chain resiliency across its hospitals and physician offices.